Amedisys, Inc. AMED
Set alert
100.99 0.00 0.00%
At close · Aug 14
100.93 Day range 101.02
82.15 52-week range 101.02
- YTD
- +11.23%
- 1 year
- +3.24%
- Open
- 101.00
- Prev close
- 100.99
- Mkt cap
- 3.32B
- Vol
- 1.04M
- Avg vol
- 549.55K
- EPS
- 2.57
- P/E
- 39.30
- Div yield
- 0.00%
More statistics
- Low
- 100.93
- High
- 101.02
- Forward P/E
- 19.76
- Beta
- 0.90
- Short ratio
- 6.84
- Inst. own
- 96.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2025
- 50-d avg
- 98.01
- 200-d avg
- 93.25
- 1y target
- 0.00
2Y chart
Events in this range
- Apr 24, 2024Earnings: —; estimate 1.01; surprise —%
- Jul 1, 2024Downgrade: William Blair · Outperform → Market Perform
- Jul 24, 2024Earnings: —; estimate 1.22; surprise —%
- Jul 25, 2024Rating: Cantor Fitzgerald · Neutral → Neutral
- Jul 31, 2024Downgrade: Deutsche Bank · Buy → Hold
- Nov 6, 2024Earnings: —; estimate 1.14; surprise —%
- Feb 12, 2025Rating: Stephens & Co. · Equal-Weight → Equal-Weight
- Feb 26, 2025Earnings: —; estimate 1.05; surprise —%
- Mar 4, 2025Rating: Stephens & Co. · Equal-Weight → Equal-Weight
- Apr 16, 2025Rating: RBC Capital · Outperform → Outperform
- Apr 23, 2025Earnings: —; estimate 1.13; surprise —%
- Jul 29, 2025Earnings: —; estimate 1.39; surprise —%
Signals (89)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 1, 2025 | 1 year ago |
| RSI: Overbought | Jun 30, 2025 | 1 year ago |
| RSI: Overbought | Jun 25, 2025 | 1 year ago |
| RSI: Overbought | Jun 23, 2025 | 1 year ago |
| RSI: Overbought | Jun 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| RSI: Overbought | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 27, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 13, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| RSI: Overbought | Jan 24, 2025 | 1 year ago |
| SMA: Bullish | Dec 31, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 20, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 17, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 3, 2024 | 1 year ago |
| RSI: Oversold | Dec 3, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 27, 2024 | 1 year ago |
| RSI: Oversold | Nov 12, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 6, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 6, 2024 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 31, 2024 | 2 years ago |
| RSI: Oversold | Oct 31, 2024 | 2 years ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 23, 2024 | 2 years ago |
| SMA: Bearish | Oct 22, 2024 | 2 years ago |
| SMA: Bullish | Oct 18, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 10, 2024 | 2 years ago |
| SMA: Bearish | Sep 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 23, 2024 | 2 years ago |
| RSI: Overbought | Jul 3, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 28, 2024 | 2 years ago |
| SMA: Bullish | Jun 27, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 26, 2024 | 2 years ago |
| SMA: Bearish | May 31, 2024 | 2 years ago |
| MACD: Sell Signal | May 31, 2024 | 2 years ago |
| RSI: Overbought | May 20, 2024 | 2 years ago |
| RSI: Overbought | May 8, 2024 | 2 years ago |
| SMA: Bullish | May 7, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 26, 2024 | 2 years ago |
| RSI: Oversold | Apr 17, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 2, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 20, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 15, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 14, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 13, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 28, 2024 | 2 years ago |
| SMA: Bearish | Feb 23, 2024 | 2 years ago |
| SMA: Bullish | Feb 22, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 22, 2024 | 2 years ago |
| SMA: Bearish | Feb 5, 2024 | 2 years ago |
| SMA: Bullish | Feb 2, 2024 | 2 years ago |
| SMA: Bearish | Jan 31, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 31, 2024 | 2 years ago |
| SMA: Bullish | Jan 26, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 26, 2024 | 2 years ago |
| SMA: Bearish | Jan 25, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 25, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 19, 2024 | 2 years ago |
| SMA: Bullish | Jan 12, 2024 | 2 years ago |
| SMA: Bearish | Jan 9, 2024 | 2 years ago |
| MACD: Sell Signal | Dec 29, 2023 | 2 years ago |
| RSI: Overbought | Dec 19, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 12, 2023 | 2 years ago |
| MACD: Sell Signal | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Nov 10, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 6, 2023 | 2 years ago |
| RSI: Oversold | Oct 26, 2023 | 3 years ago |
Key statistics
- Market cap
- 3.32B
- Enterprise value
- 3.48B
- Trailing P/E
- 39.30
- Forward P/E
- 19.76
- PEG ratio
- 0.00
- Price / sales
- 1.38
- Price / book
- 2.69
- EPS (TTM)
- 2.57
- Beta
- 0.90
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.56%
- Revenue (TTM)
- 2.40B
- Revenue growth
- 5.20%
- Free cash flow
- 300.69M
- Total cash
- 337.30M
- Total debt
- 450.51M
- Return on equity
- 6.67%
- Shares outstanding
- 32.89M
- Short % of float
- 9.90%
- 50-day average
- 98.01
- 200-day average
- 93.25
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 6 1 buy · 4 hold · 1 sell
- Strong buy1
- Buy0
- Hold4
- Sell1
- Strong sell0
Next earnings
Jul 29, 2025
Expected Jul 29, 2025. Consensus EPS estimate 1.20.
Financials — quick view
AMED Revenue — quarterly 621.86M
AMED Net income — quarterly 28.08M
AMED EPS — quarterly 0.85
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 29, 2025 | Jun 1, 2025 | 1.39 | — | — | — |
| Apr 23, 2025 | Mar 1, 2025 | 1.13 | — | — | — |
| Feb 26, 2025 | Dec 1, 2024 | 1.05 | — | — | — |
| Nov 6, 2024 | Sep 1, 2024 | 1.14 | — | — | — |
| Jul 24, 2024 | Jun 1, 2024 | 1.22 | — | — | — |
| Apr 24, 2024 | Mar 1, 2024 | 1.01 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 16, 2025 | RBC Capital | reit | Outperform | Outperform |
| Mar 4, 2025 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Feb 12, 2025 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Jul 31, 2024 | Deutsche Bank | down | Buy | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | reit | Neutral | Neutral |
| Jul 1, 2024 | William Blair | down | Outperform | Market Perform |
About Amedisys, Inc.
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- amedisys.com
News
- Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust
- Twilio Set to Join S&P MidCap 400
- Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
- Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
- Amedisys (AMED) Q2 Revenue Tops 5%
- Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
- Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
- Amedisys Reports Second Quarter 2025 Financial Results
- Here's Why You Should Retain AMED Stock in Your Portfolio for Now
- AMED or CHE: Which Is the Better Value Stock Right Now?
Your note
Sign in to keep a note on AMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ASHWORTH RICHARD M | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| BOHNERT DENISE M. | Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| CAPPS VICKIE LYNN | Director | Stock Award(Grant) | May 1, 2025 | 9,818 |
| COYE MOLLY JOEL | Director | Stock Award(Grant) | May 1, 2025 | 8,818 |
| GINN SCOTT G | Chief Financial Officer | Conversion of Exercise of derivative security | Aug 13, 2025 | 0 |
| GUIDROZ ALLYSON | Officer | Stock Award(Grant) | Aug 5, 2025 | 9,473 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.17% | 3,345,633 | 337.88M | Jun 29, 2025 |
| Vanguard Group Inc | 9.25% | 3,041,392 | 307.15M | Jun 29, 2025 |
| Pentwater Capital Management Lp | 5.22% | 1,715,084 | 173.21M | Jun 29, 2025 |
| FIL LTD | 3.99% | 1,312,785 | 132.58M | Jun 29, 2025 |
| Alpine Associates Management Inc. | 3.34% | 1,096,920 | 110.78M | Jun 29, 2025 |
| State Street Corporation | 3.25% | 1,067,613 | 107.82M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.25% | 1,067,364 | 107.79M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.14% | 1,032,785 | 104.30M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.49% | 818,018 | 82.61M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.61% | 529,664 | 53.49M | Mar 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.53% | 504,318 | 50.93M | Mar 30, 2025 |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 1.50% | 492,439 | 49.73M | Apr 29, 2025 |